EPIDEMIC MENINGITIS
Clinical trials for EPIDEMIC MENINGITIS explained in plain language.
Never miss a new study
Get alerted when new EPIDEMIC MENINGITIS trials appear
Sign up with your email to follow new studies for EPIDEMIC MENINGITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New meningitis vaccine trial for infants could offer better protection
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine against four types of meningococcal bacteria (A, C, Y, W135) that cause meningitis. About 1,040 healthy babies aged 6 to 11 months will receive either the new vaccine or an approved one. Researchers will compare immune responses and monitor safety f…
Matched conditions: EPIDEMIC MENINGITIS
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 17, 2026 11:58 UTC
-
New vaccine trial aims to shield infants from deadly meningitis
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine to protect babies aged 3 to 5 months against four types of meningococcal bacteria that cause meningitis. About 880 healthy infants will receive either the new vaccine or an existing one, with a booster shot at 12 months. Researchers will check how w…
Matched conditions: EPIDEMIC MENINGITIS
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:55 UTC
-
New meningitis vaccine trial aims to protect young children
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine to protect children aged 2 to 6 against four types of meningococcal bacteria that cause meningitis. About 660 healthy children will receive either the new vaccine or a licensed one. Researchers will check if the new vaccine triggers a strong immune …
Matched conditions: EPIDEMIC MENINGITIS
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:02 UTC
-
New meningitis vaccine for toddlers shows promise in major trial
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine to protect young children (12-23 months old) against four types of meningococcal bacteria that can cause meningitis. Around 1,040 toddlers will receive either the new vaccine or a licensed one to compare safety and immune response. The goal is to se…
Matched conditions: EPIDEMIC MENINGITIS
Phase: PHASE3 • Sponsor: Sinovac Biotech Co., Ltd • Aim: ⭐️ VACCINE ⭐️
Last updated May 07, 2026 18:41 UTC